Tumor necrosis factor (TNF) inhibitors increase the risk of infection in patients with rheumatoid arthritis (RA). In order to quantify this risk, investigators in Japan compared the records from 646 patients treated with either etanercept or infliximab and 498 treated with nonbiological drugs.; [...]